Everence Capital Management’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-9,530
| Closed | -$720K | – | 887 |
|
|
2026
Q1 | $720K | Hold |
9,530
| – | – | 0.04% | 294 |
|
|
2025
Q4 | $710K | Hold |
9,530
| – | – | 0.04% | 303 |
|
|
2025
Q3 | $643K | Hold |
9,530
| – | – | 0.04% | 324 |
|
|
2025
Q2 | $621K | Buy |
9,530
+5,640
| +145% | +$338K | 0.04% | 304 |
|
|
2025
Q1 | $240K | Buy |
+3,890
| New | +$258K | 0.02% | 666 |
|
|
2024
Q4 | – | Sell |
-4,780
| Closed | -$389K | – | 917 |
|
|
2024
Q3 | $389K | Buy |
+4,780
| New | +$382K | 0.02% | 498 |
|
|
2021
Q4 | – | Sell |
-6,559
| Closed | -$484K | – | 773 |
|
|
2021
Q3 | $484K | Hold |
6,559
| – | – | 0.04% | 412 |
|
|
2021
Q2 | $438K | Hold |
6,559
| – | – | 0.04% | 437 |
|
|
2021
Q1 | $488K | Hold |
6,559
| – | – | 0.04% | 381 |
|
|
2020
Q4 | $478K | Hold |
6,559
| – | – | 0.05% | 353 |
|
|
2020
Q3 | $436K | Hold |
6,559
| – | – | 0.05% | 340 |
|
|
2020
Q2 | $348K | Hold |
6,559
| – | – | 0.04% | 408 |
|
|
2020
Q1 | $230K | Hold |
6,559
| – | – | 0.03% | 469 |
|
|
2019
Q4 | $342K | Hold |
6,559
| – | – | 0.05% | 436 |
|
|
2019
Q3 | $331K | Hold |
6,559
| – | – | 0.05% | 400 |
|
|
2019
Q2 | $315K | Hold |
6,559
| – | – | 0.05% | 416 |
|
|
2019
Q1 | $317K | Hold |
6,559
| – | – | 0.06% | 388 |
|
|
2018
Q4 | $270K | Hold |
6,559
| – | – | 0.06% | 309 |
|
|
2018
Q3 | $269K | Hold |
6,559
| – | – | 0.05% | 341 |
|
|
2018
Q2 | $261K | Hold |
6,559
| – | – | 0.06% | 338 |
|
|
2018
Q1 | $245K | Hold |
6,559
| – | – | 0.05% | 352 |
|
|
2017
Q4 | $280K | Buy |
+6,559
| New | +$262K | 0.06% | 321 |
|
Other funds holding HOLX
Everence Capital Management's HOLX Position: Q2 2026 in Review
Everence Capital Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 9,530 shares — an estimated $720K sold.
Everence Capital Management first reported a position in HOLX in Q4 2017 and held it in 22 quarters. The position peaked at $720K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Everence Capital Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Everence Capital Management sold 9,530 Hologic shares in Q2 2026, an estimated $720K.
- Everence Capital Management first reported a position in Hologic in Q4 2017 and held it in 22 quarters.
- Everence Capital Management's Hologic position peaked at $720K in Q1 2026.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.